The Question That Arrives With Every Vaccine Reminder
“Can we just run a titer instead of giving the booster?”
I hear it several times a week. Sometimes it comes from owners who have read that vaccines last longer than the label says. Sometimes it comes from those who worry about over-vaccination. Occasionally it comes with a screenshot claiming that annual boosters are a scam.
The short answer is that titers can be useful tools. The longer, more accurate answer is that they are not a universal substitute for boosters, and the evidence in 2026 is clearer in some places than others. Let’s put the actual data on the table.
What a Titer Test Actually Measures
A titer is a blood test that looks for antibodies against a specific disease. For dogs we most commonly measure distemper, parvovirus, and sometimes adenovirus. For cats the equivalents are panleukopenia, herpesvirus, and calicivirus.
A positive (or “protective”) titer means the immune system has circulating antibodies at or above a threshold that correlates with protection in most animals. It does not measure cellular immunity, memory B-cell responses, or the ability to mount a rapid response if the antibody level later drops. It is a useful snapshot, not a complete movie of immune competence.
What the Evidence Shows About Duration of Immunity
Decades of research and challenge studies have demonstrated that many modified-live core vaccines produce immunity that lasts well beyond the traditional one-year booster interval in the majority of dogs and cats. For canine distemper and parvovirus, solid data support durations of five to seven years or longer in most animals after the initial series and a booster at one year. Similar patterns exist for feline panleukopenia.
This is why the major guidelines (AAHA, WSAVA, and others) moved years ago to triennial core vaccination for most adult pets after the appropriate initial series. The science on duration of immunity is strong and has been for some time.
Where Titers Fit—and Where They Do Not
Situations where titers are often reasonable:
Dogs or cats with a history of vaccine adverse reactions
Animals with chronic immune-mediated disease where we want to minimize immune stimulation
Owners who strongly prefer to vaccinate only when antibody levels are documented to be low
Cases in which we need documentation of immunity for boarding, travel, or legal reasons and the animal is overdue
Situations where a booster is usually the clearer choice:
Young animals still finishing their initial series
Pets with unknown or incomplete vaccine histories
Households or regions with higher infectious-disease pressure
When the titer result is equivocal or below the protective threshold
For vaccines that do not have well-validated titer correlates (many non-core vaccines fall here)
A low or negative titer is actionable: we vaccinate. A high titer is reassuring for that moment in time. It does not guarantee the animal will still be protected two or three years later without further monitoring or vaccination.
The Practical Limits I See in the Exam Room
Titer tests cost money—sometimes nearly as much as the vaccine itself, sometimes more when interpretation and follow-up are included. Results are not instantaneous. Different laboratories use different methodologies and cut-offs, which can create confusion when results are compared across clinics.
More importantly, a titer is only as good as the decision that follows it. I have seen owners interpret a single high titer as lifelong immunity and then skip monitoring for years. I have also seen animals with previously solid titers become negative on recheck, reminding us that individual variation is real.
For rabies, the conversation is largely closed in most jurisdictions. Rabies vaccination intervals are set by law, and titers are not widely accepted as substitutes for legally required boosters.
How I Actually Counsel Owners in 2026
I start with the individual animal and the local disease risk, not with a global rule.
For a healthy adult dog that completed a proper initial series and a one-year booster, I am comfortable with triennial core vaccination. If the owner prefers titers, we can run them at the time a booster would be due and use the result to decide. I document the conversation and the result so the next veterinarian understands the plan.
For cats the same logic applies to panleukopenia; the respiratory viruses are more complicated because antibody levels correlate less cleanly with protection from infection (though they still help against serious disease).
I do not push annual core boosters on most adult pets. I also do not pretend that a titer is a perfect, risk-free alternative that removes all need for future vaccines. Both positions oversell the evidence.
The Bottom Line From the Chart
The evidence supports longer duration of immunity for core modified-live vaccines than the old annual schedule assumed. Guidelines have reflected that for years. Titers are a legitimate tool for selected patients and for owners who want data before revaccinating. They are not a universal replacement, and they introduce their own costs and limitations.
The cleanest approach remains individualized: proper initial series, a booster at one year, then either triennial vaccination or titer-based decisions according to the animal’s health, the owner’s risk tolerance, and the strength of the available data.
Fear of vaccines and reflexive over-vaccination are both forms of noise. The chart—history, guidelines, titer results when used, and the individual patient—cuts through it.
Let the chart do the talking.
No letters yet — be the first to write.